Literature DB >> 25465909

Micafungin at a standard dosage of 100 mg/day achieves adequate plasma exposure in critically ill patients with severe burn injuries.

M J Asensio1, M Sánchez, B Galván, E Herrero, L Cachafeiro, A Agrifoglio, E Perales, S Luque, A García-de-Lorenzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25465909     DOI： 10.1007/s00134-014-3586-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics of caspofungin in two patients with burn injuries.

Authors:  V Jullien; B Blanchet; M Benyamina; M Tod; C Vinsonneau
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

2.  Population pharmacokinetic analysis of fluconazole to predict therapeutic outcome in burn patients with Candida infection.

Authors:  Seunghoon Han; Jimyon Kim; Haejun Yim; Jun Hur; Wonkeun Song; Jongtae Lee; Sangil Jeon; Taegon Hong; Heungjeong Woo; Dong-Seok Yim
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

3.  Micafungin concentrations in the plasma and burn eschar of severely burned patients.

Authors:  Junichi Sasaki; Satoshi Yamanouchi; Daisuke Kudo; Tomoyuki Endo; Ryosuke Nomura; Kiyotsugu Takuma; Shigeki Kushimoto; Yotaro Shinozawa; Satoshi Kishino; Shingo Hori; Naoki Aikawa
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

4.  Outcome and changes over time in survival following severe burns from 1985 to 2004.

Authors:  Nele Brusselaers; Eric A J Hoste; Stan Monstrey; Kirsten E Colpaert; Jan J De Waele; Koenraad H Vandewoude; Stijn I Blot
Journal:  Intensive Care Med       Date:  2005-10-12       Impact factor: 17.440
  4 in total
  4 in total

1.  [Not Available].

Authors:  Jf Arnould; R Le Floch
Journal:  Ann Burns Fire Disasters       Date:  2015-03-31

2.  Comparative Population Plasma and Tissue Pharmacokinetics of Micafungin in Critically Ill Patients with Severe Burn Injuries and Patients with Complicated Intra-Abdominal Infection.

Authors:  A García-de-Lorenzo; S Luque; S Grau; A Agrifoglio; L Cachafeiro; E Herrero; M J Asensio; S M Sánchez; J A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191

Review 3.  Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.

Authors:  Roeland E Wasmann; Eline W Muilwijk; David M Burger; Paul E Verweij; Catherijne A Knibbe; Roger J Brüggemann
Journal:  Clin Pharmacokinet       Date:  2018-03       Impact factor: 6.447

4.  Penetration of echinocandins into wound secretion of critically ill patients.

Authors:  Tiziana Gasperetti; René Welte; Herbert Oberacher; Jana Marx; Ingo Lorenz; Peter Schellongowski; Thomas Staudinger; Karin Burgmann; Philipp Eller; Tobias Santner; Andrea Griesmacher; Hartwig Pfisterer; Stephan Eschertzhuber; Maria Aigner; Michael Joannidis; Romuald Bellmann
Journal:  Infection       Date:  2021-04-20       Impact factor: 3.553
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.